Mercy BioAnalytics Receives FDA Approval to Initiate Prospective Pivotal Study of Evident™Ovarian Cancer Screening Test
IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis ("SOARA") Clinical Validation Study following Institutional Review Board approval WALTHAM, Mass., Sept. 21, 2026 /PRNewswire/ -- Mercy BioAnalytics, Inc. ("Mercy" or the "Company"), a...